Modeling cardiovascular disease in the zebrafish

被引:103
作者
Chico, Timothy J. A. [1 ]
Ingham, Philip W.
Crossman, David C.
机构
[1] Univ Sheffield, Lab D38 Firth Court, Med Res Council Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1016/j.tcm.2008.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The zebrafish possesses a host of advantages that have established it as an excellent model of vertebrate development. These include ease of genetic manipulation and transgenesis, optical clarity, and small size and cost. Biomedical researchers are increasingly exploiting these advantages to model human disease mechanisms. Here we review the use of the zebrafish for cardiovascular research. We summarize previous studies with the use of this organism to model such processes as thrombosis, collateral vessel development, inflammation, cardiomyopathy, and cardiac regeneration, evaluate its promise for novel drug discovery, and consider where the zebrafish fits into the framework of existing cardiovascular models.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 47 条
[1]   A three-dimensional functional assessment of heart and vessel development in the larva of the zebrafish (Danio rerio) [J].
Bagatto, B ;
Burggren, W .
PHYSIOLOGICAL AND BIOCHEMICAL ZOOLOGY, 2006, 79 (01) :194-201
[2]   Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo [J].
Blum, Yannick ;
Belting, Heinz-Georg ;
Ellertsdottir, Elin ;
Herwig, Lukas ;
Lueders, Florian ;
Affolter, Markus .
DEVELOPMENTAL BIOLOGY, 2008, 316 (02) :312-322
[3]   High-throughput assay for small molecules that modulate zebrafish embryonic heart rate [J].
Burns, CG ;
Milan, DJ ;
Grande, EJ ;
Rottbauer, W ;
MacRae, CA ;
Fishman, MC .
NATURE CHEMICAL BIOLOGY, 2005, 1 (05) :263-264
[4]  
Chen JN, 1996, DEVELOPMENT, V123, P293
[5]   Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell labeling and ablation in zebrafish [J].
Davison, Jon M. ;
Akitake, Courtney M. ;
Goll, Mary G. ;
Rhee, Jerry M. ;
Gosse, Nathan ;
Baier, Herwig ;
Halpern, Marnie E. ;
Leach, Steven D. ;
Parsons, Michael J. .
DEVELOPMENTAL BIOLOGY, 2007, 304 (02) :811-824
[6]   Knockdown of prothrombin in zebrafish [J].
Day, K ;
Krishnegowda, N ;
Jagadeeswaran, P .
BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) :191-198
[7]   FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction [J].
Engel, Felix B. ;
Hsieh, Patrick C. H. ;
Lee, Richard T. ;
Keating, Mark T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (42) :15546-15551
[8]  
Forouhar AS, 2004, P ANN INT IEEE EMBS, V26, P3615
[9]   Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy [J].
Gerull, B ;
Gramlich, M ;
Atherton, J ;
McNabb, M ;
Trombitás, K ;
Sasse-Klaassen, S ;
Seidman, JG ;
Seidman, C ;
Granzier, H ;
Labeit, S ;
Frenneaux, M ;
Thierfelder, L .
NATURE GENETICS, 2002, 30 (02) :201-204
[10]   Ischemia is not required for arteriogenesis in zebrafish embryos [J].
Gray, Caroline ;
Packham, Ian M. ;
Wurmser, Francois ;
Eastley, Nicholas C. ;
Hellewell, Paul G. ;
Ingham, Philip W. ;
Crossman, David C. ;
Chico, Timothy J. A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (10) :2135-2141